HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ching-Hon Pui Selected Research

Cranial Irradiation

1/2023Prognostic factors of childhood acute lymphoblastic leukemia with TCF3::PBX1 in CCCG-ALL-2015: A multicenter study.
12/2022The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation.
1/2021Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation.
1/2020Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
12/2019Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.
12/2018To delay or not to delay, that is the question for patients with acute lymphoblastic leukemia who do not receive prophylactic cranial irradiation.
1/2017Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy.
1/2017Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†.
7/2013Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
8/2009Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ching-Hon Pui Research Topics

Disease

223Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2024 - 01/2002
84Leukemia
04/2024 - 04/2002
68Neoplasms (Cancer)
12/2023 - 04/2002
41Residual Neoplasm
11/2023 - 06/2002
23Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 10/2002
20Infections
03/2024 - 09/2003
17Osteonecrosis (Kienbock's Disease)
10/2022 - 10/2004
15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2023 - 02/2009
14Hypersensitivity (Allergy)
01/2023 - 09/2005
13Philadelphia Chromosome
09/2023 - 01/2009
9Hematologic Neoplasms (Hematological Malignancy)
10/2022 - 04/2010
8Genetic Predisposition to Disease (Genetic Predisposition)
03/2024 - 01/2006
7Obesity
01/2024 - 12/2002
7Thrombosis (Thrombus)
07/2023 - 08/2003
7Pain (Aches)
01/2022 - 03/2008
7Leukoencephalopathies
10/2016 - 12/2004
6Febrile Neutropenia
01/2020 - 04/2008
6Second Primary Neoplasms (Neoplasms, Second)
10/2019 - 07/2002
5Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 02/2015
5Overweight
01/2021 - 12/2006
4Sepsis (Septicemia)
03/2024 - 09/2003
4Pancreatitis
01/2023 - 12/2009
4Central Nervous System Diseases (CNS Diseases)
12/2022 - 01/2006
4Neuralgia (Stump Neuralgia)
01/2022 - 12/2011
4Brain Neoplasms (Brain Tumor)
01/2021 - 02/2005
4Hypothyroidism
12/2019 - 04/2006
4Hodgkin Disease (Hodgkin's Disease)
01/2018 - 03/2006
4Neutropenia
03/2011 - 01/2004
3Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2024 - 08/2008
3Tumor Lysis Syndrome
11/2023 - 03/2003
3Seizures (Absence Seizure)
12/2019 - 08/2003
3Chronic Disease (Chronic Diseases)
10/2019 - 07/2009
3Hypogonadism (Hypergonadotropic Hypogonadism)
06/2019 - 07/2007
3Glucosephosphate Dehydrogenase Deficiency
01/2019 - 04/2002
3Hyperglycemia
01/2017 - 12/2002
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2016 - 11/2002
3Acute Kidney Injury (Acute Renal Failure)
12/2016 - 09/2012

Drug/Important Bio-Agent (IBA)

39Methotrexate (Mexate)FDA LinkGeneric
02/2024 - 07/2002
28Asparaginase (Elspar)FDA Link
04/2024 - 12/2002
19GlucocorticoidsIBA
05/2023 - 12/2002
17Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 11/2004
14Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2024 - 01/2002
13Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 02/2002
12DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2004
11Tyrosine Kinase InhibitorsIBA
09/2023 - 01/2009
10Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023 - 10/2002
9Dasatinib (BMS 354825)FDA Link
09/2023 - 01/2020
8Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2005
8AntibodiesIBA
01/2023 - 01/2011
8Etoposide (VP 16)FDA LinkGeneric
01/2021 - 04/2002
7ChromatinIBA
12/2023 - 11/2019
7pegaspargase (Oncaspar)FDA Link
01/2023 - 10/2019
7Growth Hormone (Somatotropin)IBA
01/2021 - 07/2002
7NucleotidesIBA
01/2021 - 06/2003
62-mercaptopurineIBA
01/2024 - 01/2002
6SteroidsIBA
05/2023 - 12/2002
6Messenger RNA (mRNA)IBA
01/2023 - 08/2006
6Clofarabine (Clolar)FDA Link
12/2022 - 08/2011
6RNA (Ribonucleic Acid)IBA
11/2022 - 04/2015
6EnzymesIBA
01/2021 - 03/2003
6Thioguanine (Tioguanine)FDA Link
01/2021 - 06/2003
6Indicators and Reagents (Reagents)IBA
04/2015 - 06/2002
5Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 09/2003
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2012
5AntimetabolitesIBA
01/2020 - 11/2004
5rasburicase (Elitek)FDA Link
01/2019 - 04/2002
5Prednisone (Sone)FDA LinkGeneric
01/2019 - 01/2004
4Imatinib Mesylate (Gleevec)FDA Link
09/2023 - 01/2018
4Phosphotransferases (Kinase)IBA
01/2022 - 08/2012
4Opioid Analgesics (Opioids)IBA
01/2022 - 12/2011
4AntigensIBA
01/2021 - 06/2011
4Folic Acid (Vitamin M)FDA LinkGeneric
12/2020 - 10/2004
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2006
4gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA
05/2014 - 07/2002
3Chimeric Antigen ReceptorsIBA
01/2023 - 01/2021
3blinatumomabIBA
12/2022 - 12/2020
3Gabapentin (Neurontin)FDA LinkGeneric
01/2022 - 12/2011
3Sorafenib (BAY 43-9006)FDA Link
01/2022 - 08/2011
3Transcription Factors (Transcription Factor)IBA
11/2021 - 09/2014
3venetoclaxIBA
01/2021 - 01/2020
3Prednisolone (Predate)FDA LinkGeneric
01/2020 - 08/2004
3Alkylating AgentsIBA
12/2019 - 10/2014
3Daunorubicin (Cerubidine)FDA LinkGeneric
10/2019 - 08/2004
3purineIBA
01/2016 - 09/2004
3Dihydrotachysterol (AT 10)IBA
12/2013 - 07/2007

Therapy/Procedure

153Therapeutics
04/2024 - 02/2002
85Drug Therapy (Chemotherapy)
05/2024 - 07/2002
28Remission Induction
11/2023 - 07/2002
18Radiotherapy
01/2020 - 08/2003
15Cranial Irradiation
01/2023 - 01/2004
10Hematopoietic Stem Cell Transplantation
01/2023 - 10/2003
10Aftercare (After-Treatment)
10/2022 - 08/2004
8Cell Transplantation
01/2023 - 02/2006
4Immunotherapy
01/2023 - 01/2019
4Induction Chemotherapy
01/2021 - 03/2011
4Anesthesia
01/2020 - 11/2007
4Transplantation
07/2013 - 02/2010
3Central Venous Catheters
09/2022 - 07/2009
3Antibiotic Prophylaxis
01/2021 - 07/2008
3Combination Drug Therapy (Combination Chemotherapy)
07/2013 - 04/2005